Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enalapril orodispersible minitablets in children with dilated cardiomyopathy
2015-002335-17Phase 3Completed
- Sponsor
- Ethicare Clinical Trial Services
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of enalapril in heart failure (HF) and dilated cardiomyopathy (DCM), sponsored by Ethicare Clinical Trial Services. Primary endpoint: Enalapril and enalaprilat bioavailability in the pediatric population. Started Sep 2015; status: completed.
02
Drugs
enalapril
03
Conditions
heart failure (HF)dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on 2015-002335-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002335-17.